5 completed, 3 unknown, 1 recruiting. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 5, Unknown 3, Recruiting 1 |
Follow Dyspareunia: new trials by email Literature Review of Dyspareunia trials Research Report on Dyspareunia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postpartum Vaginal Estrogen for Breastfeeding Patients Estradiol, Vaginal Moisturizer - Breastfeeding, Postpartum Sexual Dysfunction | Phase 4 | Recruiting | University Hospitals Cleveland Medical Center | 100 | 2025-02-22 | 2026-07-23 |
| Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia Prasterone - Dyspareunia | Phase 4 | Completed | San Diego Sexual Medicine | 18 | 2018-08-07 | 2022-06-09 |
| Treating Postmenopausal Dyspareunia Where it Hurts 50mcg estradiol cream, 100mcg estradiol cream - Dyspareunia | Phase 4 | Completed | Oregon Health and Science University | 50 | 2017-06-20 | 2023-05-22 |
| A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction Botulinum toxin A 50u, Botulinum toxin A 100u, Botulinum toxin A 150u - Pelvic Pain, Dyspareunia | Phase 4 | Completed | EvergreenHealth | 20 | 2017-05-25 | 2021-06-10 |
| Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA Ospemifene - Vulvovaginal Atrophy, Dyspareunia | Phase 4 | Completed | Sue Goldstein | 10 | 2015-07-01 | 2019-04-02 |
| Continuous Versus Cyclic Oral Contraceptives for Endometriosis Oral contraceptives cyclic, Oral contraceptives continuous - Dysmenorrhea, Pelvic Pain | Phase 4 | Unknown | University of Athens | 50 | 2014-04-01 | 2014-09-11 |
| Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride, Pelvic Rehabilitation - Dyspareunia | Phase 4 | Unknown | University of Cincinnati | 36 | 2013-08-01 | 2013-12-30 |
| Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome Changing the Interstim parameter of '' Frequency" in patients with Interstitial Cystitis - Painful Bladder Syndrome, Interstitial Cystitis | Phase 4 | Unknown | Pelvic and Sexual Health Institute | 72 | 2011-04-01 | 2014-04-29 |
| Dilators for Dyspareunia Prevention Dilator use - Post-operative Dyspareunia | Phase 4 | Completed | Medstar Health Research Institute | 60 | 2010-09-01 | 2015-04-09 |
Pelvic Pain (2) · Sexual Dysfunction, Physiological (2) · Vaginismus (2) · Breast Feeding (1) · Constipation (1) · Cystitis, Interstitial (1) · Dysmenorrhea (1) · Endometriosis (1) · Fecal Incontinence (1) · Intestinal Diseases (1) · Pain, Postoperative (1) · Prolapse (1) · Vulvodynia (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Diseases, Male (9) · Male Urogenital Diseases (9) · Mental Disorders (9) · Sexual Dysfunctions, Psychological (9) · Urogenital Diseases (9) · Sexual Dysfunction, Physiological (7) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Neurologic Manifestations (3) · Pain (3) · Pathologic Processes (2)
Botulinum Toxins, Type A (1) · Bupivacaine (1) · Dehydroepiandrosterone (1) · Estradiol (1) · Ospemifene (1) · drospirenone and ethinyl estradiol combination (1)
EvergreenHealth (1) · Medstar Health Research Institute (1) · Oregon Health and Science University (1) · Pelvic and Sexual Health Institute (1) · San Diego Sexual Medicine (1) · Sue Goldstein (1) · University Hospitals Cleveland Medical Center (1) · University of Athens (1) · University of Cincinnati (1)
United States (8) · Greece (1)
Irwin Goldstein, MD (2) · Kristene E Whitmore, MD (1) · Martha Goetsch, MD, MPH (1) · Mary South, MD (1) · Mia A. Swartz, MD (1) · Nikos Vlahos, AssProfessor (1) · Olga Triantafyllidou, MD (1) · Rachel Pope, MD (1) · Sue W Goldstein, BA, CCRC (1)
PMID 15089868, PMID 17195176, PMID 19222415, PMID 23812462, PMID 29678557, PMID 35231008, PMID 36787525